نتائج البحث - "Sonia Maciá"

1

دورية أكاديمية

961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2051-1426Test

الوصول الحر: https://doaj.org/article/cfa232992c194eb9b490f0ff34e0deecTest

View record in DOAJ

النص الكامل

2

Novel Therapies in Clinical Development for Advanced Disease

المؤلفون: Álvaro Sánchez Arráez, Sonia Maciá, Eduardo Castañón

المصدر: Melanoma-Standard of Care, Challenges, and Updates in Clinical Research
Melanoma-Standard of Care, Challenges, and Updates in Clinical Research ISBN: 9781803563985

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8454fc6e0404c0255195ebdf208bb4e9Test
https://mts.intechopen.com/articles/show/title/novel-therapies-in-clinical-development-for-advanced-diseaseTest

3

Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)

المؤلفون: José Luis González-Larriba, María Isabel Sáez, Marta López-Brea, Cristina Caballero, Alejo Rodriguez-Vida, Sonia Maciá, Alain Ravaud, Joaquim Bellmunt, Emilio Esteban, Daniel Castellano, Emiliano Calvo, Aristotelis Bamias

المصدر: BJU International. 126:559-567

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c3b69bf04a0fea4cfa93b73290e2b73fTest
https://doi.org/10.1111/bju.15165Test

4

961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e402ca5ac12d03a7ed527395e7f52c31Test
https://doaj.org/article/cfa232992c194eb9b490f0ff34e0deecTest

5

Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients

المصدر: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International Journal of Radiation Oncology Biology Physics
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

مصطلحات موضوعية: Male, Biochemical recurrence, Cancer Research, medicine.medical_specialty, Randomization, medicine.medical_treatment, Urology, Docetaxel, Adenocarcinoma, Disease-Free Survival, Drug Administration Schedule, 030218 nuclear medicine & medical imaging, law.invention, Gonadotropin-Releasing Hormone, Androgen deprivation therapy, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Randomized controlled trial, law, Humans, Medicine, Radiology, Nuclear Medicine and imaging, Aged, Radiation, business.industry, Prostate, Prostatic Neoplasms, Androgen Antagonists, Radiotherapy Dosage, Middle Aged, Prostate-Specific Antigen, medicine.disease, Combined Modality Therapy, Radiation therapy, Clinical trial, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Neoplasm Grading, business, medicine.drug